Hong Kong Wound Care Market Research Report: By Type (Advanced, Traditional), Application (Chronic Wounds, Acute Wounds), End User (Hospitals and Specialty Clinics, Home Healthcare, Long-Term Care Settings), Distribution Channel (Pharmacies, Online Channels) - Industry Analysis and Growth Forecast to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Distribution Channel

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By industry participant

2.2.1.2 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Market Definition

4.1.1 By Type

4.1.1.1 Advanced

4.1.1.1.1 Wound dressings

4.1.1.1.1.1 Foam

4.1.1.1.1.2 Hydrocolloid

4.1.1.1.1.3 Film

4.1.1.1.1.4 Alginate

4.1.1.1.1.5 Antimicrobial

4.1.1.1.1.6 Hydrogel

4.1.1.1.1.7 Collagen

4.1.1.1.1.8 Hydrofiber

4.1.1.1.1.9 Wound contact layer

4.1.1.1.1.10 Superabsorbent

4.1.1.1.1.11 Others

4.1.1.1.2 Wound therapy devices

4.1.1.1.2.1 NPWT devices

4.1.1.1.2.2 Pressure relief devices

4.1.1.1.2.3 Others

4.1.1.1.3 Wound care biologics

4.1.1.1.3.1 Skin substitutes

4.1.1.1.3.2 Collagen-based

4.1.1.1.3.3 Growth factors

4.1.1.1.3.4 Others

4.1.1.2 Traditional

4.1.1.2.1 Bandages

4.1.1.2.2 Fixation tapes

4.1.1.2.3 Gauzes

4.1.1.2.4 Sponges

4.1.1.2.5 Abdominal pads

4.1.1.2.6 Others

4.1.2 By Application

4.1.2.1 Chronic wounds

4.1.2.1.1 DFUs

4.1.2.1.2 Pressure ulcers

4.1.2.1.3 VLUs

4.1.2.1.4 Others

4.1.2.2 Acute wounds

4.1.2.2.1 Surgical and traumatic wounds

4.1.2.2.2 Burns

4.1.2.2.3 Others

4.1.3 By End User

4.1.3.1 Hospitals and specialty clinics

4.1.3.1.1 Inpatient settings

4.1.3.1.2 Outpatient settings

4.1.3.2 Home healthcare

4.1.3.3 Long-term care settings

4.1.4 By Distribution Channel

4.1.4.1 Pharmacies

4.1.4.2 Online channels

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Shift in preference from traditional products to advanced therapies

4.2.2 Drivers

4.2.2.1 Growing geriatric population

4.2.2.2 Increasing prevalence of diabetes

4.2.2.3 High incidence of traumatic injuries

4.2.2.4 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of advanced wound care products

4.2.3.2 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Improving economy and increasing health expenditure

4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management

4.3 Impact of COVID-19

4.4 Porter’s Five Forces Analysis

4.5 Regulatory Overview

4.6 Wound Dressing Product Pricing

4.7 Healthcare Insurance Scenario in Hong Kong

Chapter 5. Epidemiology of Wounds in Hong Kong

5.1 Total Incidence of Wounds

5.2 Type-Specific Incidence of Wounds

5.2.1 Incident Cases of Acute Wounds, by Subtype

5.2.2 Incident Cases of Chronic Wounds, by Subtype

Chapter 6. Hong Kong Market Size and Forecast

6.1 By Type

6.1.1 Advanced Wound Care Market, by Type

6.1.1.1 Advanced wound dressing market, by type

6.1.1.1.1 Foam dressing market

6.1.1.1.1.1 By hospital type

6.1.1.1.1.2 By prescription mode

6.1.1.1.2 Hydrocolloid dressing market

6.1.1.1.2.1 By hospital type

6.1.1.1.2.2 By prescription mode

6.1.1.1.3 Film dressing market

6.1.1.1.3.1 By hospital type

6.1.1.1.3.2 By prescription mode

6.1.1.1.4 Alginate dressing market

6.1.1.1.4.1 By hospital type

6.1.1.1.4.2 By prescription mode

6.1.1.1.5 Antimicrobial dressing market

6.1.1.1.5.1 By hospital type

6.1.1.1.5.2 By prescription mode

6.1.1.1.6 Hydrogel dressing market

6.1.1.1.6.1 By hospital type

6.1.1.1.6.2 By prescription mode

6.1.1.1.7 Collagen dressing market

6.1.1.1.7.1 By hospital type

6.1.1.1.7.2 By prescription mode

6.1.1.1.8 Hydrofiber dressing market

6.1.1.1.8.1 By hospital type

6.1.1.1.8.2 By prescription mode

6.1.1.1.9 Wound contact layer dressing market

6.1.1.1.9.1 By hospital type

6.1.1.1.9.2 By prescription mode

6.1.1.1.10 Superabsorbent dressing market

6.1.1.1.10.1 By hospital type

6.1.1.1.10.2 By prescription mode

6.1.1.2 Wound care biologics market, by type

6.1.1.2.1 Skin substitutes market, by type

6.1.1.3 Wound therapy devices market, by type

6.1.2 Traditional Wound Dressing Market, by Type

6.2 By Application

6.2.1 Wound Dressing Market for Chronic Wounds, by Type

6.2.2 Wound Dressing Market for Acute Wounds, by Type

6.3 By End User

6.3.1 Wound Dressing Market in Hospitals and Specialty Clinics, by Type

6.4 By Distribution Channel

Chapter 7. Competitive Landscape

7.1 Company Benchmarking Based on Product Offerings

7.2 Revenue Share Analysis of Major Companies

7.2.1 3M Company

7.2.2 ConvaTec Group Plc

7.2.3 Coloplast A/S

7.2.4 PAUL HARTMANN Asia-Pacific Ltd.

7.2.5 Winner Medical Co. Ltd.

7.2.6 Mölnlycke Health Care AB

7.2.7 Smith & Nephew plc

7.3 Advanced Wound Dressing Usage Share Analysis, by Hospital

7.3.1 Government Hospitals

7.3.1.1 Tuen Mun Hospital (TMH)

7.3.1.2 United Christian Hospital (UCH)

7.3.1.3 Queen Elizabeth Hospital (QEH)

7.3.1.4 Prince of Wales Hospital (PWH)

7.3.1.5 Pamela Youde Nethersole Eastern Hospital (PYNEH)

7.3.1.6 Princess Margaret Hospital (PMH)

7.3.1.7 Queen Mary Hospital (QMH)

7.3.2 Private Hospitals

7.3.2.1 Evangel Hospital

7.3.2.2 Gleneagles Hong Kong Hospital

7.3.2.3 Hong Kong Adventist Hospital

7.3.2.4 Hong Kong Baptist Hospital

7.3.2.5 Hong Kong Sanatorium & Hospital Limited

7.3.2.6 Matilda & War Memorial Hospital

7.3.2.7 Precious Blood Hospital

7.3.2.8 St. Paul's Hospital

7.3.2.9 St. Teresa's Hospital

7.3.2.10 Union Hospital

7.3.2.11 Canossa Hospital

7.4 Strategic Developments of Key Players

7.4.1 Mergers and Acquisitions

7.4.2 Partnerships

7.4.3 Other Developments

Chapter 8. Company Profiles

8.1 Coloplast A/S

8.1.1 Business Overview

8.1.2 Product and Service Offerings

8.1.3 Key Financial Summary

8.2 3M Company

8.2.1 Business Overview

8.2.2 Product and Service Offerings

8.2.3 Key Financial Summary

8.3 Paul Hartmann AG

8.3.1 Business Overview

8.3.2 Product and Service Offerings

8.3.3 Key Financial Summary

8.4 Winner Medical Co. Ltd.

8.4.1 Business Overview

8.4.2 Product and Service Offerings

8.5 Mölnlycke Health Care AB

8.5.1 Business Overview

8.5.2 Product and Service Offerings

8.5.3 Key Financial Summary

8.6 Smith & Nephew plc

8.6.1 Business Overview

8.6.2 Product and Service Offerings

8.6.3 Key Financial Summary

8.7 ConvaTec Group PLC

8.7.1 Business Overview

8.7.2 Product and Service Offerings

8.7.3 Key Financial Summary

8.8 Allmed Medical Products Co. Ltd.

8.8.1 Business Overview

8.8.2 Product and Service Offerings

8.9 Zhende Medical Co. Ltd.

8.9.1 Business Overview

8.9.2 Product and Service Offerings

8.10 Wayson Medical Co. Ltd.

8.10.1 Business Overview

8.10.2 Product and Service Offerings

8.11 B. Braun Melsungen AG

8.11.1 Business Overview

8.11.2 Product and Service Offerings

8.11.3 Key Financial Summary

8.12 BSN medical GmbH

8.12.1 Business Overview

8.12.2 Product and Service Offerings

8.13 Beiersdorf AG

8.13.1 Business Overview

8.13.2 Product and Service Offerings

8.13.3 Key Financial Summary

8.14 Johnson & Johnson

8.14.1 Business Overview

8.14.2 Product and Service Offerings

8.14.3 Key Financial Summary

8.15 Urgo Medical

8.15.1 Business Overview

8.15.2 Product and Service Offerings

8.16 Cardinal Health Inc.

8.16.1 Business Overview

8.16.2 Product and Service Offerings

8.16.3 Key Financial Summary

8.17 Medtronic plc

8.17.1 Business Overview

8.17.2 Product and Service Offerings

8.17.3 Key Financial Summary

8.18 Integra LifeSciences Holdings Corporation

8.18.1 Business Overview

8.18.2 Product and Service Offerings

8.18.3 Key Financial Summary

8.19 Wright Medical Group N.V.

8.19.1 Business Overview

8.19.2 Product and Service Offerings

8.19.3 Key Financial Summary

8.20 Medela Healthcare

8.20.1 Business Overview

8.20.2 Product and Service Offerings

8.21 Lohmann & Rauscher GmbH & Co. KG

8.21.1 Business Overview

8.21.2 Product and Service Offerings

8.22 Nitto Denko Corporation

8.22.1 Business Overview

8.22.2 Product and Service Offerings

8.22.3 Key Financial Summary

8.23 Weigao Group Co. Ltd.

8.23.1 Business Overview

8.23.2 Product and Service Offerings

8.23.3 Key Financial Summary

Chapter 9. Appendix

9.1 Abbreviations

9.2 Sources and References

9.3 Related Report

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 PRICING OF SOME MAJORLY USED WOUND DRESSING PRODUCTS

TABLE 5 TOTAL INCIDENCE OF WOUNDS IN HONG KONG (2019–2024)

TABLE 6 TOTAL INCIDENCE OF WOUNDS IN HONG KONG (2025–2030)

TABLE 7 TYPE-SPECIFIC INCIDENCE OF WOUNDS IN HONG KONG (2019–2024)

TABLE 8 TYPE-SPECIFIC INCIDENCE OF WOUNDS IN HONG KONG (2025–2030)

TABLE 9 INCIDENT CASES OF ACUTE WOUNDS, BY SYBTYPE IN HONG KONG (2019–2024)

TABLE 10 INCIDENT CASES OF ACUTE WOUNDS, BY SYBTYPE IN HONG KONG (2025–2030)

TABLE 11 INCIDENT CASES OF CHRONIC WOUNDS, BY SYBTYPE IN HONG KONG (2019–2024)

TABLE 12 INCIDENT CASES OF CHRONIC WOUNDS, BY SYBTYPE IN HONG KONG (2025–2030)

TABLE 13 HONG KONG WOUND CARE MARKET, BY TYPE, $’000 (2019–2024)

TABLE 14 HONG KONG WOUND CARE MARKET, BY TYPE, $’000 (2025–2030)

TABLE 15 HONG KONG ADVANCED WOUND CARE MARKET, BY TYPE, $’000 (2019–2024)

TABLE 16 HONG KONG ADVANCED WOUND CARE MARKET, BY TYPE, $’000 (2025–2030)

TABLE 17 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2019–2024)

TABLE 18 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 19 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2019–2024)

TABLE 20 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2025–2030)

TABLE 21 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 22 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 23 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 24 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 25 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 26 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 27 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 28 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 29 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 30 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 31 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 32 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 33 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 34 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 35 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 36 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 37 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (